ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,446.00
      2.17%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      82.765
      0.00%
      Bitcoin
      63,872.01
      -0.03%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC
      6. RepliCel Life Sciences Inc (PK) (REPCF)

      7. RepliCel Life Sciences Inc (PK) (REPCF) News

      REPCF

      RepliCel Life Sciences (PK) (REPCF)

      RepliCel Life Sciences Inc (PK)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:USOTC:REPCF
      DateTimeSourceHeadlineSymbolCompany
      11/30/20231:05PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (PK)
      10/24/202311:10AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (PK)
      10/19/20231:45PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (PK)
      10/04/20232:23PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (PK)
      09/07/202312:26PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (PK)
      08/30/20235:15PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (PK)
      08/29/20231:14PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (PK)
      08/17/202311:22AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:REPCFRepliCel Life Sciences Inc (PK)
      05/31/20236:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (PK)
      05/18/20231:59PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (PK)
      04/20/20231:04PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:REPCFRepliCel Life Sciences Inc (PK)
      03/16/20232:40PMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:REPCFRepliCel Life Sciences Inc (PK)
      02/08/20236:01AMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:REPCFRepliCel Life Sciences Inc (PK)
      02/02/20236:02AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (PK)
      01/26/202310:51AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:REPCFRepliCel Life Sciences Inc (PK)
      01/26/20236:01AMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:REPCFRepliCel Life Sciences Inc (PK)
      01/17/202312:02PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (PK)
      01/17/202311:48AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (PK)
      01/06/20236:02AMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:REPCFRepliCel Life Sciences Inc (PK)
      12/09/20226:03AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (PK)
      10/25/202212:28PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (PK)
      09/29/20226:02AMEdgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:REPCFRepliCel Life Sciences Inc (PK)
      09/13/20226:01AMEdgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)USOTC:REPCFRepliCel Life Sciences Inc (PK)
      09/06/20222:36PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (PK)
      08/04/202211:41AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (PK)
      07/28/20222:53PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (PK)
      07/26/20221:46PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (PK)
      07/07/20221:44PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (PK)
      06/30/202211:16AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:REPCFRepliCel Life Sciences Inc (PK)
      06/29/20226:02AMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:REPCFRepliCel Life Sciences Inc (PK)
       Showing the most relevant articles for your search:USOTC:REPCF